Framingham and the Muddy Waters Jeffry N. Gerber, MD Denver’s Diet Doctor.

Slides:



Advertisements
Similar presentations
CV Health: Three Ways to ‘kNOw’
Advertisements

PAD Rehabilitation Toolkit A Guide for Healthcare Professionals Healthy Steps for Peripheral Artery Disease (PAD) Developed by AACVPR and the Vascular.
Grazie per aver scelto di utilizzare a scopo didattico questo materiale delle Guidelines 2011 libra. Le ricordiamo che questo materiale è di proprietà.
New concepts and guidelines in the management of LDL-c and CV Risk: Need for early intervention Prof. Ulf Landmesser University Hospital Zürich Switzerland.
1 Prediabetes Comorbidities and Complications. 2 Common Comorbidities of Prediabetes Obesity CVD Dyslipidemia Hypertension Renal failure Cancer Sleep.
PAD A Call to Action. PAD: A Call to Action - What is peripheral arterial disease (PAD)? and why is it so dangerous? - Diagnosing PAD in the primary care.
Presenter Disclosure Information Paul M Ridker, MD, FACC Dr Ridker is listed as a co-inventor on patents held by the Brigham and Women’s Hospital that.
CVD prevention & management: a new approach for primary care Rod Jackson School of Population Health University of Auckland New Zealand.
Slide Source: Lipids Online Slide Library High-Density Lipoprotein and the Epidemiology of Coronary Heart Disease Michael Miller,
Presenter Disclosure Information Diane Bild, MD, MPH Screening for Subclinical Atherosclerosis as a Strategy for CVD Prevention FINANCIAL DISCLOSURE: None.
Screening for Prediabetes Kelly Moore, MD, FAAP IHS Division of Diabetes Treatment & Prevention.
Copyright © 2008 Delmar. All rights reserved. Chapter 21 Populations with Chronic Diseases.
Diabetes Mellitus Type 2
Dr Hassan Makki DO FACC Phoenix Heart Center.  Diabetes mellitus (DM) is a group of diseases characterized by high levels of blood glucose resulting.
Only You Can Prevent CVD Matthew Johnson, MD. What can we do to prevent CVD?
COMMON LIFESTYLE DISEASES
Heart Disease Effects of lifestyle on coronary heart disease Sara Quale ∙ Concordia University-Nebraska 1.
Metabolic Syndrome, Diabetes, and Cardiovascular Disease: Implications for Preventive Cardiology Nathan D. Wong, PhD, FACC, FAHA Professor and Director.
1 Comparing Zero Coronary Artery Calcium With Other Negative Risk Factors for Coronary Heart Disease A Novel Methodology: Risk-Adjusted Negative Likelihood.
Management of Dyslipidemia in Patients with Peripheral Arterial Disease: an update from Guidelines Oman International Vascular Conference Al-Bustan Palace.
Therapy of Type 2 Diabetes Mellitus: UPDATE
METABOLIC SYNDROME Dr Gerhard Coetzer. Complaint Thirsty all the time Urinating more than usual Blurred vision Tiredness.
METABOLIC Syndrome: a Global Perspective
Coronary Artery Disease Angina Pectoris Unstable Angina Variant Angina Joseph D. Lynch, MD.
New guidelines for CABG
The use of hospital pharmacy profiles to identify patients with metabolic syndrome and their history of nutrition intervention from a registered dietitian.
Obesity, Metabolic Syndrome and Diabetes in Hispanics: implications on Cardiovascular Disease 2011 Eduardo de Marchena M.D., F.A.C.C., F.A.C.P. Professor.
Metabolic Syndrome Yusra Mir, MD Zunairah Syed, MD Harjagjit Maan, MD.
Modern Management of Cholesterol in the High-Risk Patient.
Leveraging Weight Loss in the Treatment of Type 2 Diabetes Part 1 of 4.
Towards better screening of CV risk Paul Ridker MD Associate Professor of Medicine Division of Preventive Medicine and Cardiovascular Diseases Harvard.
The Obesity/Diabetes Epidemic: Perspectives, Consequences, Prevention, Treatment Stan Schwartz MD, FACP, FACE Private Practice, Ardmore Obesity Program.
Ethnic Differences in the Prognostic Value of Coronary Artery Calcification for All-Cause Mortality Khurram Nasir MD MPH, Leslee J. Shaw PhD, Sandy T.
The Obesity/Diabetes Epidemic: Adiposopathy & ‘Obesity’- The New Disease! Weight Management in Obesity and DM: Emphasis on New Medical Therapies Stan Schwartz.
The Obesity/Diabetes Epidemic: Adiposopathy & ‘Obesity’- The New Disease! Weight Management in Obesity and DM: Emphasis on New Medical Therapies Stan Schwartz.
Predictive Value of Coronary Calcium Scoring Matthew Budoff, MD, FACC, FAHA Associate Professor of Medicine UCLA School of Medicine Director, Cardiac CT.
Dr. I. Selvaraj Indian Railways Medical Service B.Sc., M.B.B.S., M.D.,D.P.H., D.I.H., PGCHFW ( NIHFW,New Delhi)., Life member of Indian Association of.
Insulin Resistance Progression to Diabetes. Hypertension: BP >140/90 Dyslipidemia: ◦TG >150 mg/dL (1.7 mmol.L) ◦HDL-C
Diabetes Health intelligence Jon Walker Advanced public health analyst Surrey County Council
Monitoring Physical Health Stephen R. Marder, M.D. Professor, Semel Institute for Neuroscience and Human Behavior at UCLA Director, VA VISN 22 Mental Illness.
South Asians Cardiovascular Disease Ashley Marion University of Guelph-Humber Brampton Civic Hospital Cardiac Rehabilitation
The IDEAL Cholesterol Christopher Cannon, M.D. TIMI Study Group Brigham and Women’s Hospital Cannon CP. JAMA 2005;294:
Vascular effects of PPAR  activation: Inflammation.
2013 ACC/AHA Guideline on the Treatment of Blood Cholesterol to Reduce Atherosclerotic Cardiovascular Risk in Adults Scott W. Rypkema, M.D.
Are We There Yet ? Abdul H. Sankari, MD FACC FCCP.
INTERVENTION IS PREVENTION: For A Healthier Community Bronx County Medical Society 10 th Annual National Doctors Recognition Day March 20, 2013 Julie J.
Abstract The metabolic syndrome (MetS) has surpassed smoking as the number one cause of cardiovascular deaths in the US. However, it remains under diagnosed.
Yusra Mir, MD Zunairah Syed, MD Harjagjit Maan, MD
N323: Parent-Child Nursing
The role of unknown risk factors in coronary heart disease
Pathophysiology and Prevention of Heart Disease in Diabetes Mellitus
Peak oxygen uptake and prevalence of cardiovascular disease risk factors in breast cancer survivors Lahart1, I.M., Metsios1, G.S., Nevill1, A.M., Kitas1,2,
2013 ACC/AHA cholesterol treatment guidelines
Phenotype vs. Genotype: Defining Severe Familial Hypercholesterolemia
Triglycerides Cholesterol HDL-C or N NIDDM N or or N IDDM.
FATS- Familial Atherosclerosis Treatment Study
Heart Health & Diabetes
Macrovascular Complications Microvascular Complications
The following slides highlight a report on a presentation at the Canadian Cardiovascular Congress held in Toronto, Ontario from October 24 to 29, 2003.
Metabolic Syndrome (N=160) Non-Metabolic Syndrome (N=138) 107/53
Type 2 diabetes: Overlap of clinical conditions
Description of studies for pooled analyses
2013 ACC/AHA cholesterol treatment guidelines
Contemporary Evidence-Based Guidelines
Goals & Guidelines A summary of international guidelines for CHD
Cardiovascular Disease in Women Module III: Risk Assessment Tool
Preventative Cardiology
Case 1: A 78-year-old white female with hypertension and hyperlipidemia Discussion Points: In that this patient has documented atherosclerotic vascular.
University College London
Presentation transcript:

Framingham and the Muddy Waters Jeffry N. Gerber, MD Denver’s Diet Doctor

“Those with cardiovascular disease not identified with diabetes… are simply undiagnosed” - Dr. Joseph R. Kraft

Dr. Joseph R. Kraft - diabetes-epidemic.com

FBG>100 mg/dl (5.5 mmol/l) screening 2hr OGTT>140 mg/dl (7.8 mmol/l) HbA1c Standard Methods Inferior

Gold standard based on RIA insulin (uIU/ml) 14,384 subjects, 5hr glucose plus insulin Defined 5 distinct patterns 3 patterns of hyperinsulinemia – Diabetes In-Situ Redefining diabetes at its earliest stage Dr. Kraft 5hr Insulin Assay

Image curtesy Ivor Cummins BE(Chem) CEng MIEI Pattern 1 - Euinsulinemia

Image curtesy Ivor Cummins BE(Chem) CEng MIEI Patterns 2,3,4 - Hyperinsulinemia

Image curtesy Ivor Cummins BE(Chem) CEng MIEI Patterns 5 - Insulinopenic

Hyperinsulinemia before Hyperglycemia Catherine Crofts M.Phil, B.Pharm, NZRegPharm, PhD Candidate Public Health. Images curtesy Ivor Cummins BE(Chem) CEng MIEI

Glucose vs. Insulin Data recompiled from Kraft J. R. Diabetes Epidemic & You. 2011

Euglycemia

Hyperglycemia

NHANES prevalence 2015: 49%-52% in the US now pre-diabetic or diabetic UCLA 2016: 55% of Californians are pre- diabetic or diabetic Kraft would predict that many more have hyperinsulinemia Predicting population risk Menke A, et al. JAMA. 2015;314(10): doi: /jama healthpolicy.ucla.edu/publications/search/pages/detail.aspx?PubID=1472

Diabetes Paradox? Despite more diabetes & obesity there’s less heart disease Morbidity & mortally not to be confused with incidence and prevalence Diabetes Care March 2003 vol. 26 no doi: /diacare

Atherosclerosis is a metabolic disease Missing pre-diabetes and diabetes also misses cardiovascular disease Dr. Kraft on CV risk

Gerald M. Reaven, MD Diabetes December 1988 vol. 37 no doi: /diab Slide curtesy lipidsonline.org

Lipids, Smoking, HTN, Diabetes Guidelines, risk calculators Lowering cholesterol Diabetes risk buried Framingham Distraction

Hyperlipidemia requires remedy Mechanisms remains elusive Diet-heart hypothesis unproven Statins provide small benefit Lipid Lowering Therapy

Get with the Guidelines 2009 Towards a Paradigm Shift in Cholesterol Treatment 2015 Debunking the Lipid Hypothesis

Mark A. Creager et al. Circulation. 2003;108: Hyperinsulinemia and blood vessel damage

Framingham risk calculators: CV risk increased 2-3 fold (middle risk population) Diabetes alone: CV risk increased 6-8 fold Framingham vs. Diabetes Risk Circulation. 2002; 105: e132-e137 doi: /01.CIR

Atherosclerosis is a symptom of diabetes Focus insulin excess, IR, and inflammation Many at risk are missed Diet and lifestyle, not medicine It’s the Insulin Stupid!

Low carb best Eliminating processed food Eating less Movement & activity Smoking cessation Proper sleep & happiness Diet and Lifestyle

Early level of suspicion FBG & HbA1c - are poor screening tools alone 2 hr OGTT including 1hr glucose <155 mg/dl (8.6 mmol/l) Insulin - fasting, 5hr assay, 2hr <30 uIU/ml Inflammatory markers, lipid quality, etc… Clinical assessment doi:

Heart catheterization CIMT IVUS CT angiogram Coronary artery calcium score Cardiovascular imaging

CAC Score J Am Coll Cardiol Img. 2015;8(5):

CAC Progression Arterioscler Thromb Vasc Biol. 2004;24:

Diabetes is a Vascular Disease

Hyperinsulinism, Inflammation & Adiposity